Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Lung Cancer Test Kit Market Growth 2022-2028

  • RnM4484114
    • |
  • 18 August, 2022
    • |
  • Global
    • |
  • 119 Pages
    • |
  • LPI(LP Information)
    • |
  • Medical Devices & Consumables

The global market for Lung Cancer Test Kit is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Lung Cancer Test Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Lung Cancer Test Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Lung Cancer Test Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Lung Cancer Test Kit market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Lung Cancer Test Kit players cover Asuragen, Fujirebio, Swift Biosciences, Xian Tianlong Science and Technology Co.,Ltd and Jiangsu Mole Bioscience CO., LTD., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Lung Cancer Test Kit market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Lung Cancer Test Kit market, with both quantitative and qualitative data, to help readers understand how the Lung Cancer Test Kit market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Lung Cancer Test Kit market and forecasts the market size by Type (Non-Small Cell Lung Cancer and Small Cell Lung Cancer,), by Application (Hospitals and Cancer Research Centers.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Non-Small Cell Lung Cancer
Small Cell Lung Cancer

Segmentation by application
Hospitals
Cancer Research Centers

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Asuragen
Fujirebio
Swift Biosciences
Xian Tianlong Science and Technology Co.,Ltd
Jiangsu Mole Bioscience CO., LTD.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Gencurix
HTG Molecular
Jiangsu MicroDiag Biomedicine Technology Co., Ltd
IDL Biotech
LCM Genect srl
Panagene Inc.
Beijing ACCB Biotech Ltd.
ViennaLab Diagnostics
Genetic Biotek

Chapter Introduction
Chapter 1: Scope of Lung Cancer Test Kit, Research Methodology, etc.
Chapter 2: Executive Summary, global Lung Cancer Test Kit market size (sales and revenue) and CAGR, Lung Cancer Test Kit market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lung Cancer Test Kit sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lung Cancer Test Kit sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lung Cancer Test Kit market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Asuragen, Fujirebio, Swift Biosciences, Xian Tianlong Science and Technology Co.,Ltd, Jiangsu Mole Bioscience CO., LTD., Jiangsu Macro & Micro-Test Med-Tech Co., Ltd., Gencurix, HTG Molecular and Jiangsu MicroDiag Biomedicine Technology Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Lung Cancer Test Kit Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Lung Cancer Test Kit by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Lung Cancer Test Kit by Country/Region, 2017, 2022 & 2028
  • 2.2 Lung Cancer Test Kit Segment by Type
    • 2.2.1 Non-Small Cell Lung Cancer
    • 2.2.2 Small Cell Lung Cancer
  • 2.3 Lung Cancer Test Kit Sales by Type
    • 2.3.1 Global Lung Cancer Test Kit Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Lung Cancer Test Kit Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Lung Cancer Test Kit Sale Price by Type (2017-2022)
  • 2.4 Lung Cancer Test Kit Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Cancer Research Centers
  • 2.5 Lung Cancer Test Kit Sales by Application
    • 2.5.1 Global Lung Cancer Test Kit Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Lung Cancer Test Kit Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Lung Cancer Test Kit Sale Price by Application (2017-2022)

3 Global Lung Cancer Test Kit by Company

  • 3.1 Global Lung Cancer Test Kit Breakdown Data by Company
    • 3.1.1 Global Lung Cancer Test Kit Annual Sales by Company (2020-2022)
    • 3.1.2 Global Lung Cancer Test Kit Sales Market Share by Company (2020-2022)
  • 3.2 Global Lung Cancer Test Kit Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Lung Cancer Test Kit Revenue by Company (2020-2022)
    • 3.2.2 Global Lung Cancer Test Kit Revenue Market Share by Company (2020-2022)
  • 3.3 Global Lung Cancer Test Kit Sale Price by Company
  • 3.4 Key Manufacturers Lung Cancer Test Kit Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Lung Cancer Test Kit Product Location Distribution
    • 3.4.2 Players Lung Cancer Test Kit Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Lung Cancer Test Kit by Geographic Region

  • 4.1 World Historic Lung Cancer Test Kit Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Lung Cancer Test Kit Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Lung Cancer Test Kit Annual Revenue by Geographic Region
  • 4.2 World Historic Lung Cancer Test Kit Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Lung Cancer Test Kit Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Lung Cancer Test Kit Annual Revenue by Country/Region
  • 4.3 Americas Lung Cancer Test Kit Sales Growth
  • 4.4 APAC Lung Cancer Test Kit Sales Growth
  • 4.5 Europe Lung Cancer Test Kit Sales Growth
  • 4.6 Middle East & Africa Lung Cancer Test Kit Sales Growth

5 Americas

  • 5.1 Americas Lung Cancer Test Kit Sales by Country
    • 5.1.1 Americas Lung Cancer Test Kit Sales by Country (2017-2022)
    • 5.1.2 Americas Lung Cancer Test Kit Revenue by Country (2017-2022)
  • 5.2 Americas Lung Cancer Test Kit Sales by Type
  • 5.3 Americas Lung Cancer Test Kit Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Lung Cancer Test Kit Sales by Region
    • 6.1.1 APAC Lung Cancer Test Kit Sales by Region (2017-2022)
    • 6.1.2 APAC Lung Cancer Test Kit Revenue by Region (2017-2022)
  • 6.2 APAC Lung Cancer Test Kit Sales by Type
  • 6.3 APAC Lung Cancer Test Kit Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Lung Cancer Test Kit by Country
    • 7.1.1 Europe Lung Cancer Test Kit Sales by Country (2017-2022)
    • 7.1.2 Europe Lung Cancer Test Kit Revenue by Country (2017-2022)
  • 7.2 Europe Lung Cancer Test Kit Sales by Type
  • 7.3 Europe Lung Cancer Test Kit Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Lung Cancer Test Kit by Country
    • 8.1.1 Middle East & Africa Lung Cancer Test Kit Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Lung Cancer Test Kit Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Lung Cancer Test Kit Sales by Type
  • 8.3 Middle East & Africa Lung Cancer Test Kit Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Lung Cancer Test Kit
  • 10.3 Manufacturing Process Analysis of Lung Cancer Test Kit
  • 10.4 Industry Chain Structure of Lung Cancer Test Kit

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Lung Cancer Test Kit Distributors
  • 11.3 Lung Cancer Test Kit Customer

12 World Forecast Review for Lung Cancer Test Kit by Geographic Region

  • 12.1 Global Lung Cancer Test Kit Market Size Forecast by Region
    • 12.1.1 Global Lung Cancer Test Kit Forecast by Region (2023-2028)
    • 12.1.2 Global Lung Cancer Test Kit Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Lung Cancer Test Kit Forecast by Type
  • 12.7 Global Lung Cancer Test Kit Forecast by Application

13 Key Players Analysis

  • 13.1 Asuragen
    • 13.1.1 Asuragen Company Information
    • 13.1.2 Asuragen Lung Cancer Test Kit Product Offered
    • 13.1.3 Asuragen Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Asuragen Main Business Overview
    • 13.1.5 Asuragen Latest Developments
  • 13.2 Fujirebio
    • 13.2.1 Fujirebio Company Information
    • 13.2.2 Fujirebio Lung Cancer Test Kit Product Offered
    • 13.2.3 Fujirebio Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Fujirebio Main Business Overview
    • 13.2.5 Fujirebio Latest Developments
  • 13.3 Swift Biosciences
    • 13.3.1 Swift Biosciences Company Information
    • 13.3.2 Swift Biosciences Lung Cancer Test Kit Product Offered
    • 13.3.3 Swift Biosciences Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Swift Biosciences Main Business Overview
    • 13.3.5 Swift Biosciences Latest Developments
  • 13.4 Xian Tianlong Science and Technology Co.,Ltd
    • 13.4.1 Xian Tianlong Science and Technology Co.,Ltd Company Information
    • 13.4.2 Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Test Kit Product Offered
    • 13.4.3 Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Xian Tianlong Science and Technology Co.,Ltd Main Business Overview
    • 13.4.5 Xian Tianlong Science and Technology Co.,Ltd Latest Developments
  • 13.5 Jiangsu Mole Bioscience CO., LTD.
    • 13.5.1 Jiangsu Mole Bioscience CO., LTD. Company Information
    • 13.5.2 Jiangsu Mole Bioscience CO., LTD. Lung Cancer Test Kit Product Offered
    • 13.5.3 Jiangsu Mole Bioscience CO., LTD. Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Jiangsu Mole Bioscience CO., LTD. Main Business Overview
    • 13.5.5 Jiangsu Mole Bioscience CO., LTD. Latest Developments
  • 13.6 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
    • 13.6.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
    • 13.6.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Test Kit Product Offered
    • 13.6.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Main Business Overview
    • 13.6.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Latest Developments
  • 13.7 Gencurix
    • 13.7.1 Gencurix Company Information
    • 13.7.2 Gencurix Lung Cancer Test Kit Product Offered
    • 13.7.3 Gencurix Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Gencurix Main Business Overview
    • 13.7.5 Gencurix Latest Developments
  • 13.8 HTG Molecular
    • 13.8.1 HTG Molecular Company Information
    • 13.8.2 HTG Molecular Lung Cancer Test Kit Product Offered
    • 13.8.3 HTG Molecular Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 HTG Molecular Main Business Overview
    • 13.8.5 HTG Molecular Latest Developments
  • 13.9 Jiangsu MicroDiag Biomedicine Technology Co., Ltd
    • 13.9.1 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Company Information
    • 13.9.2 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Test Kit Product Offered
    • 13.9.3 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Main Business Overview
    • 13.9.5 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Latest Developments
  • 13.10 IDL Biotech
    • 13.10.1 IDL Biotech Company Information
    • 13.10.2 IDL Biotech Lung Cancer Test Kit Product Offered
    • 13.10.3 IDL Biotech Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 IDL Biotech Main Business Overview
    • 13.10.5 IDL Biotech Latest Developments
  • 13.11 LCM Genect srl
    • 13.11.1 LCM Genect srl Company Information
    • 13.11.2 LCM Genect srl Lung Cancer Test Kit Product Offered
    • 13.11.3 LCM Genect srl Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 LCM Genect srl Main Business Overview
    • 13.11.5 LCM Genect srl Latest Developments
  • 13.12 Panagene Inc.
    • 13.12.1 Panagene Inc. Company Information
    • 13.12.2 Panagene Inc. Lung Cancer Test Kit Product Offered
    • 13.12.3 Panagene Inc. Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Panagene Inc. Main Business Overview
    • 13.12.5 Panagene Inc. Latest Developments
  • 13.13 Beijing ACCB Biotech Ltd.
    • 13.13.1 Beijing ACCB Biotech Ltd. Company Information
    • 13.13.2 Beijing ACCB Biotech Ltd. Lung Cancer Test Kit Product Offered
    • 13.13.3 Beijing ACCB Biotech Ltd. Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Beijing ACCB Biotech Ltd. Main Business Overview
    • 13.13.5 Beijing ACCB Biotech Ltd. Latest Developments
  • 13.14 ViennaLab Diagnostics
    • 13.14.1 ViennaLab Diagnostics Company Information
    • 13.14.2 ViennaLab Diagnostics Lung Cancer Test Kit Product Offered
    • 13.14.3 ViennaLab Diagnostics Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 ViennaLab Diagnostics Main Business Overview
    • 13.14.5 ViennaLab Diagnostics Latest Developments
  • 13.15 Genetic Biotek
    • 13.15.1 Genetic Biotek Company Information
    • 13.15.2 Genetic Biotek Lung Cancer Test Kit Product Offered
    • 13.15.3 Genetic Biotek Lung Cancer Test Kit Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Genetic Biotek Main Business Overview
    • 13.15.5 Genetic Biotek Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Lung Cancer Test Kit. Industry analysis & Market Report on Lung Cancer Test Kit is a syndicated market report, published as Global Lung Cancer Test Kit Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Lung Cancer Test Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,821.86
5,643.72
3,389.16
6,778.32
560,858.40
1,121,716.80
308,647.80
617,295.60
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo